XIX International Workshop on CLL 2021 - Virtual Satellite Symposium
PDF 1 09/2021
Evolving Role of BTK Inhibitors in R/R CLL – A Rational Approach to Improving Patient Outcomes
Agenda:
| SPEAKER | TOPIC |
| Anna Schuh (Chair) | Welcome, introductions and objectives |
| Federico Pea | A pharmacologist’s view on the rationale for using different BTK inhibitors for R/R CLL |
| Wojciech Jurczak | Evolving strategies with next generation BTK inhibitors as treatment for R/R CLL patients |
| Othman Al-Sawaf | 2 patient case reports in R/R CLL |
| Anna Schuh (Moderator) | Panel discussion |
| Anna Schuh | Audience Q&A |
Rating
